State Street’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,791
| Closed | -$55.1K | – | 4758 |
|
|
2023
Q1 | $55.1K | Hold |
6,791
| – | – | ﹤0.01% | 4478 |
|
|
2022
Q4 | $80.5K | Hold |
6,791
| – | – | ﹤0.01% | 4432 |
|
|
2022
Q3 | $94K | Hold |
6,791
| – | – | ﹤0.01% | 4484 |
|
|
2022
Q2 | $238K | Hold |
6,791
| – | – | ﹤0.01% | 4122 |
|
|
2022
Q1 | $271K | Buy |
6,791
+788
| +13% | +$31.4K | ﹤0.01% | 4276 |
|
|
2021
Q4 | $254K | Hold |
6,003
| – | – | ﹤0.01% | 4245 |
|
|
2021
Q3 | $408K | Hold |
6,003
| – | – | ﹤0.01% | 4057 |
|
|
2021
Q2 | $462K | Buy |
6,003
+5,362
| +837% | +$413K | ﹤0.01% | 3887 |
|
|
2021
Q1 | $42K | Buy |
641
+91
| +17% | +$5.96K | ﹤0.01% | 3949 |
|
|
2020
Q4 | $19K | Hold |
550
| – | – | ﹤0.01% | 3869 |
|
|
2020
Q3 | $30K | Hold |
550
| – | – | ﹤0.01% | 3785 |
|
|
2020
Q2 | $21K | Hold |
550
| – | – | ﹤0.01% | 3768 |
|
|
2020
Q1 | $14K | Hold |
550
| – | – | ﹤0.01% | 3717 |
|
|
2019
Q4 | $27K | Hold |
550
| – | – | ﹤0.01% | 3755 |
|
|
2019
Q3 | $27K | Hold |
550
| – | – | ﹤0.01% | 3754 |
|
|
2019
Q2 | $50K | Sell |
550
-273
| -33% | -$24.8K | ﹤0.01% | 3725 |
|
|
2019
Q1 | $122K | Sell |
823
-8
| -1% | -$1.19K | ﹤0.01% | 3625 |
|
|
2018
Q4 | $131K | Sell |
831
-8
| -1% | -$1.26K | ﹤0.01% | 3615 |
|
|
2018
Q3 | $206K | Buy |
839
+29
| +4% | +$7.12K | ﹤0.01% | 3599 |
|
|
2018
Q2 | $182K | Buy |
810
+79
| +11% | +$17.8K | ﹤0.01% | 3577 |
|
|
2018
Q1 | $179K | Buy |
731
+43
| +6% | +$10.5K | ﹤0.01% | 3566 |
|
|
2017
Q4 | $212K | Buy |
688
+104
| +18% | +$32K | ﹤0.01% | 3557 |
|
|
2017
Q3 | $214K | Buy |
+584
| New | +$214K | ﹤0.01% | 3597 |
|